Cortechs.ai | Neuroimaging biomarkers for AD
Contact

Neuroimaging biomarkers for AD

  • Category: Published research

Structural Functional And Molecular Neuroimaging Biomarkers For Alzheimer’s Disease

Magnetic resonance spectroscopy (MRS) has long showed promise for detection of regional chemical changes associated with neurodegeneration, infl ammation, or gliosis, and so it has been a technique of interest for detecting such changes in AD. It provides information about relative concentrations of key chemicals, such as N acetylaspartate, creatinine, and myoinositol, and there is strong evidence that the regional concentration of these chemicals varies with the neurodegeneration seen in AD. (2013).

[button]Download[/button]

  • Topic: Published research

More Resources

Cortechs.ai | Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health
  • 2 mins

03/09/2025

Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health

AI-driven MRI with NeuroQuant® enhances TBI assessment, tracks recovery, and supports better treatment decisions.

Cortechs.ai | Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury
  • < 1 mins

03/06/2025

Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury

This case highlights the power of advanced neuroimaging tools in delivering precise, evidence-based diagnostics to enhance patient care and clinical decisions.

Cortechs.ai | Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking
  • 3 mins

02/26/2025

Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

NeuroQuant enables objective brain volume tracking for early TBI detection, recovery monitoring, and safer return-to-play decisions.

Cortechs.ai | Neuroimaging biomarkers for AD
  • 2 mins

02/25/2025

OnQ™ Prostate Solution Enhances Collaboration and Improves MRI for Cancer Detection with RSI Technology

OnQ Prostate enhances MRI tissue characterization, improving sensitivity and specificity in cancer detection, & bridges gaps between radiologists and urologists

Cortechs.ai | Neuroimaging biomarkers for AD
  • 3 mins

02/15/2025

NeuroQuant® Dementia: Advancing Alzheimer’s Disease Care in the Era of DMTs

AI-driven brain volumetric analysis is revolutionizing Alzheimer’s care, providing precise diagnostic support, monitoring, and early detection.

Cortechs.ai | Neuroimaging biomarkers for AD
  • 3 mins

02/09/2025

NeuroQuant® MS:  Advancing Precision in Multiple Sclerosis

Dr. Suzie Bash discusses NeuroQuant MS, noting its ability to segment plaques, analyze volume, and track lesion burden for assessing disease progression

View our insights
Cortechs.ai | Neuroimaging biomarkers for AD
Cortechs.ai | Neuroimaging biomarkers for AD

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | Neuroimaging biomarkers for AD
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top